A survey of cardiac surgeons to evaluate the use of sutureless aortic valve replacement in Canada.

Background: Sutureless aortic valve replacement (SuAVR) is gaining popularity for the treatment of aortic stenosis. We aimed to describe Canadian cardiac surgeons' practice patterns and perceptions regarding SuAVR.Methods: Content experts (clinicians and methodologists) developed the survey. Domains...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cardiac Surgery Vol. 37; no. 11; pp. 3543 - 3550
Autores principales: Makhdoum, Ahmad, Kim, Kevin, Koziarz, Alex, Reza, Seleman, Alsagheir, Ali, Pandey, Arjun, Teoh, Kevin, Alhazzani, Waleed, Lamy, Andre, Yanagawa, Bobby, Belley‐Cote, Emilie P., Whitlock, Richard, Belley-Cote, Emilie P
Formato: research randomized controlled trial Journal Article
Publicado: Wiley-Blackwell Nov2022
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Background: Sutureless aortic valve replacement (SuAVR) is gaining popularity for the treatment of aortic stenosis. We aimed to describe Canadian cardiac surgeons' practice patterns and perceptions regarding SuAVR.Methods: Content experts (clinicians and methodologists) developed the survey. Domains in the questionnaire include: respondent characteristics, factors influencing the decision to implant a SuAVR, barriers to SuAVR use, and interest in participating in a trial.Results: A total of 66 cardiac surgeons (median duration of practice: 15 years; range 8-20 years) from 18 hospitals across Canada responded to the survey for a response rate of 84%. Surgeons reported that the following patient characteristics increased the likelihood they would choose SuAVR: hostile root (73%), small annular size (55%), high Society of Thoracic Surgery risk score (42%), older age (40%), to support minimally invasive surgery (25%) and redo-operation (23%). The following patient characteristics made surgeons less likely to pursue SuAVR: young age (73%), low STS score (40%), and large annular size (30%). Reported barriers to SuAVR use included: cost (33%), permanent pacemaker risk (27%) and uncertain durability (12%). Of respondents, 73% were interested in participating in a randomized controlled trial comparing SuAVR with transcatheter aortic valve replacement.Conclusions: The primary reasons for surgeons selecting SuAVR were high surgical risk and anatomical challenges. Cost is a primary factor limiting SuAVR use.